SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in China Ceramics Co., Ltd. (CCCL) to Contact the Firm

NEW YORK, NY -- (Marketwired) -- 06/14/14 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in China Ceramics Co., Ltd. ("China Ceramics" or the "Company") (NASDAQ: CCCL) of the August 5, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against China Ceramics and certain executives and directors.

A complaint has been filed in the Southern District of New York on behalf of all persons who purchased China Ceramics common stock between March 30, 2012 and May 1, 2014 (the "Class Period").

The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.

The complaint further alleges that the defendants failed to disclose and/or materially misstated its true financial condition. On May 1, 2014, NASDAQ announced that trading in China Ceramics was halted that day for "additional information requested" from the Company. On that same day, China Ceramics announced, among other things, that: (i) on April 30, 2014, the Company terminated the engagement of Grant Thornton as its principal independent registered public accountants; (ii) following the decision to terminate Grant Thorton, William L. Stulginsky tendered his resignation as an independent director and Chairman of the Audit Committee; (iii) the audit of the Company's consolidated financial statements for the year ended December 31, 2013 has not been completed; (iv) the Company is unable to timely file its Annual Report on Form 20-F for the year ended December 31, 2013; and (v) during the preparation of its 2013 financial statements the Company identified a write down of assets for the fourth quarter resulting from unused capacity at its Hengdali facility, which is currently estimated to be $7.5 million.

According the complaint, trading in China Ceramics stock remains halted rendering it illiquid and virtually worthless.

Request more information now by clicking here: www.faruqilaw.com/CCCL. There is no cost or obligation to you.

Take Action

If you invested in China Ceramics stock or options between March 30, 2012 and May 1, 2014 and would like to discuss your legal rights, visit www.faruqilaw.com/CCCL. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding China Ceramics' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Email Contact
Telephone: (877) 247-4292 or (212) 983-9330

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.